8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 2, 2014

Stericycle, Inc.

(Exact name of registrant as specified in its charter)

Delaware	0-21229	36-3640402
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification Number)

28161 North Keith Drive

Lake Forest, Illinois 60045

(Address of principal executive offices including zip code)

(847) 367-5910

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]    Written communications pursuant to Rule 425 under the Securities Act (17 CR 230.425)

[ ]    Soliciting material pursuant to Rule 14a-12 under the Securities Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 2, 2014, Stericycle, Inc. issued a press release announcing that its board of directors has unanimously selected Daniel V. Ginnetti, currently Stericycle’s Vice President of Corporate Finance, to succeed Frank J.M. ten Brink as Chief Financial Officer effective August 1, 2014. Mr. ten Brink will continue in his role as Chief Financial Officer through the transition to Mr. Ginnetti, and thereafter, will continue at Stericycle as Senior Vice President, Mergers and Acquisitions.

A copy of our press release is included as Exhibit 99.1 to this report.

Item 9.01    Financial Statements and Exhibits.

(d)    Exhibits

99.1    Press release issued by Stericycle, Inc. dated June 2, 2014.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: June 2, 2014		Stericycle, Inc.
	By:	/s/ Frank J.M. ten Brink
		Frank J.M. ten Brink
		Executive Vice President and Chief Financial Officer

EXHIBIT INDEX

Exhibit NumberDescription

99.1            Press Release issued by Stericycle, Inc. dated June 2, 2014.

EX-99.1

EXHIBIT 99.1

FOR FURTHER INFORMATION CONTACT:     FOR IMMEDIATE RELEASEFrank ten Brink 847-607-2012

Daniel Ginnetti Appointed as Executive Vice President and Chief Financial Officer Effective August 1, 2014; Frank ten Brink to remain Senior VP Mergers & Acquisitions

Lake Forest, Illinois, June 2, 2014 – Stericycle, Inc. (NASDAQ: SRCL) today announced that its board of directors has unanimously selected Daniel V. Ginnetti, currently Stericycle’s Vice President of Corporate Finance, to succeed Frank ten Brink as Chief Financial Officer effective August 1, 2014. Frank ten Brink will continue in his role as Chief Financial Officer through the transition to Mr. Ginnetti, and thereafter, Mr. ten Brink will continue at Stericycle as Senior Vice President, Mergers and Acquisitions. These changes are part of the Company’s long-term executive succession planning process.

“Frank has provided great leadership throughout Stericycle’s growth beginning in 1997 when he joined the company as CFO. We look forward to him continuing to lead our M&A effort for years to come.” said Charles A. Alutto, President and Chief Executive Officer. “Dan has also been a key contributor to Stericycle’s success over the past 11 years. He is a seasoned executive with a proven track record in finance and operations, and has a wealth of experience in all facets of our business. All of us welcome Dan to his new position and look forward to working with him as CFO.”

“The decision to transition Dan into the CFO role, which allows me to continue as Senior Vice President, Mergers and Acquisitions, was planned and coordinated with the full support of the executive team and the Board. I remain firmly committed to Stericycle and plan to remain an active member of the senior management team for years to come,” said Mr. ten Brink. “I have worked closely with Dan ever since he joined Stericycle, 11 years ago, and I am confident that he will be outstanding in his new role as CFO”.

Dan Ginnetti joined Stericycle as Area Vice President of Finance in 2003. In 2004 he was promoted to Area Vice President for Stericycle’s Western, and later, Midwestern business units. Following that, Dan was promoted to Senior Vice President of Operations for the United States and Canada. Prior to joining Stericycle, Mr. Ginnetti held various finance and accounting positions with The Ralph M. Parsons Company, a worldwide engineering firm, and Ryan Herco Products Corp., a national industrial plastics distributor. Mr. Ginnetti has a BS degree in Business Economics from the University of California, Santa Barbara.

Stericycle’s press releases and other information are available on the Company’s website at www.stericycle.com.

Safe Harbor Statement: This press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.